Why a deformy group would focus so much attention on ATRS -- not exactly the crucial education issue ... After all, who values experience anymore? You could …
Chaim Katzman is the founder, controlling shareholder and Chairman of Gazit-Globe, a leading international real estate company listed on the Tel Aviv Stock Exchange (TASE: GZT) and the New York Stock Exchange (NYSE: GZT) and the …
The stock has a consensus rating of “Buy” and a consensus price target of $3.83. Shares of Antares Pharma (ATRS) traded up 0.96% during midday trading on Tuesday, reaching $3.14. The company’s stock had a trading volume of …
The firm's market cap is $479.47 million. The stock decreased 0.36% or GBX 0.15 on August 7, reaching GBX 42.1. Goldman Sachs Group Inc. raised its stake in Antares Pharma Inc (NASDAQ:ATRS) by 338.0% during the first quarter, …
Jw Asset Management Llc acquired 252,205 shares as Antares Pharma Inc (ATRS)'s stock 0.00%. Stock analysts expect that Antares Pharma, to post ($0.13) EPS for the full year. 05/14/2015 - Antares Pharma, Inc. was upgraded to "hold" …
Jersey, 16 August 2017: Atrium European Real Estate Limited (VSE/Euronext: ATRS), ("Atrium" or the "Company" and …
The stock Hit its 1-year high of $3.24 on 04/26/17 and its 1-year low price of $0.92 on 06/24/16. Schwab Charles Management stated it has 0% of its portfolio in Antares Pharma Inc (NASDAQ:ATRS). Geode Cap Mngmt Lc invested …
Certainly when we check their stock price, it is evident that their progress has been reflected in their stock price. ATRS has been on an incredible run the past two years. It has gone from about 1.30/share to 5.25/share that is about a 323% …
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only ... At Antares Pharma ( ATRS), a filing with the SEC revealed that on …
NASDAQ2mon